Cardiovascular Risk in Acromegaly

1 Dekkers OM, Biermasz NR, Pereira AM, Romijn JA, Vandenbroucke JP. Mortality in acromegaly: a metaanalysis. J Clin Endocrinol Metab. 2008; 93:61–67. Search in Google Scholar

2 Holdaway IM, Rajasoorya RC, Gamble GD. Factors influencing mortality in acromegaly. J Clin Endocrinol Metab. 2004; 89:667–674. Search in Google Scholar

3 Melmed S, Bronstein MD, Chanson P, Klibanski A, Casanueva FF, Wass JAH, Strasburger CJ, Luger A, Clemmons DR, Giustina A. A Consensus Statement on acromegaly therapeutic outcomes. Nat Rev Endocrinol. 2018; 14:552–561. Search in Google Scholar

4 Bolanowski M, Ruchała M, Zgliczyński W, Kos-Kudła B, Bałdys-Waligórska A, Zieliński G, Bednarczuk T, Hubalewska-Dydejczyk A, Kamiński G, Marek B, Daroszewski J, Waśko R, Lewiński A. Akromegalia - nowe spojrzenie na pacjenta. Polskie propozycje postępowania diagnostyczno-terapeutycznego w akromegalii w świetle aktualnych doniesień Endokrynologia Polska. 2014; 65:326–331. Search in Google Scholar

5 Lie JT. Pathology of the heart in acromegaly: anatomic findings in 27 autopsied patients. Am Heart J. 1980; 100:41-52. Search in Google Scholar

6 Frustaci A, Chimenti C, Setoguchi M, Guerra S, Corsello S, Crea F, Leri A, Kajstura J, Anversa P, Maseri A. Cell death in acromegalic cardiomyopathy. Circulation. 1999; 99:1426-1434 Search in Google Scholar

7 Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ, Schmidt U, Semigran MJ, Dec GW, Khaw BA. Apoptosis in myocytes in end-stage heart failure. N Engl J Med. 1996; 335:1182–1189. Search in Google Scholar

8 Sabbah HN, Sharov VG. Apoptosis in heart failure. Prog Cardiovasc Dis. 1998; 40:549-562. Search in Google Scholar

9 Bihan H, Espinosa C, Valdes-Socin H, Salenave S, Young J, Levasseur S, Assayag P, Beckers A, Chanson P. Long-term outcome of patients with acromegaly and congestive heart failure. J Clin Endocrinol Metab. 2004; 89:5308–5313. Search in Google Scholar

10 Casini AF, Neto LV, Fontes R, França RF, Xavier SS, Gadelha MR. Aortic root ectasia in patients with acromegaly: experience at a single center. Clin Endocrinol (Oxf). 2011; 75:495–500. Search in Google Scholar

11 Saccà L, Napoli R, Cittadini A. Growth hormone, acromegaly, and heart failure: an intricate triangulation. Clin Endocrinol (Oxf). 2003; 59:660–671. Search in Google Scholar

12 Colao A, Spinelli L, Marzullo P, Pivonello R, Petretta M, Di Somma C, Vitale G, Bonaduce D, Lombardi G. High prevalence of cardiac valve disease in acromegaly: an observational, analytical, case-control study. J Clin Endocrinol Metab. 2003; 88:3196-201. Search in Google Scholar

13 de Jong S, van Veen TAB, van Rijen HVM, de Bakker JMT. Fibrosis and cardiac arrhythmias. J Cardiovasc Pharmacol. 2011; 57:630-638. Search in Google Scholar

14 Seale WL, Gang ES, Peter CT. The use of signal-averaged electrocardiography in predicting patients at high risk for sudden death. Pacing Clin Electrophysiol. 1990; 13:796-807. Search in Google Scholar

15 Kahaly G, Olshausen KV, Mohr-Kahaly S, Erbel R, Boor S, Beyer J, Meyer J. Arrhythmia profile in acromegaly. Eur Heart J. 1992; 13:51-56. Search in Google Scholar

16 Rodrigues EA, Caruana MP, Lahiri A, Nabarro JD, Jacobs HS, Raftery EB. Subclinical cardiac dysfunction in acromegaly: evidence for a specific disease of heart muscle. Br Heart J. 1989; 62:185–194. Search in Google Scholar

17 Vitale G, Pivonello R, Auriemma RS, Guerra E, Milone F, Savastano S, Lombardi G, Colao A. Hypertension in acromegaly and in the normal population: prevalence and determinants. Clin Endocrinol (Oxf). 2005; 63:470–476. Search in Google Scholar

18 Ikkos D, Luft R, Sjögren B. Body water and sodium in patients with acromegaly 1. J Clin Invest. 1954; 33:989–994. Search in Google Scholar

19 Møller J, Nielsen S, Hansen TK. Growth hormone and fluid retention. Horm Res. 1999; 51(Suppl 3):116–120. Search in Google Scholar

20 Kamenický P, Mazziotti G, Lombès M, Giustina A, Chanson P. Growth hormone, insulin-like growth factor-1, and the kidney: pathophysiological and clinical implications. Endocr Rev. 2014; 35:234-281. Search in Google Scholar

21 Deray G, Chanson P, Maistre G, Warnet A, Eurin J, Barthelemy C, Masson F, Martinez F, Lubetzki J, Legrand JC. Atrial natriuretic factor in patients with acromegaly. Eur J Clin Pharmacol. 1990; 38:409–413. Search in Google Scholar

22 Møller J, Jørgensen JO, Marqversen J, Frandsen E, Christiansen JS. Insulin-like growth factor I administration induces fluid and sodium retention in healthy adults: possible involvement of renin and atrial natriuretic factor. Clin Endocrinol (Oxf). 2000; 52:181-186. Search in Google Scholar

23 Karlberg BE, Ottosson A-M. Acromegaly and hypertension: role of the renin-angiotensin-aldosterone system. Acta Endocrinol. 1982; 100:581-587. Search in Google Scholar

24 Clemmons DR. Roles of insulin-like growth factor-I and growth hormone in mediating insulin resistance in acromegaly. Pituitary. 2002; 5:181-183. Search in Google Scholar

25 Colao A, Ferone D, Marzullo P, Lombardi G. Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management. Endocrine Reviews. 2004; 25:102–52. Search in Google Scholar

26 Weiss V, Sonka K, Pretl M, Dostálová S, Klozar J, Rambousek P, Marek J, Haas T. Prevalence of the sleep apnea syndrome in acromegaly population. J Endocrinol Invest. 2000; 23:515-519. Search in Google Scholar

27 Pivonello R, Auriemma RS, Grasso LF, Pivonello C, Simeoli C, Patalano R, Galdiero M, Colao A. Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities. Pituitary. 2017; 20:46-62. Search in Google Scholar

28 Nishijima T, Tajima K, Yamashiro Y, Hosokawa K, Suwabe A, Takahashi K, et al. Elevated Plasma Levels of Soluble (Pro)Renin Receptor in Patients with Obstructive Sleep Apnea Syndrome in Parallel with the Disease Severity. Tohoku J Exp Med. 2016; 238:325-38. Search in Google Scholar

29 Møller DS, Lind P, Strunge B, Pedersen EB. Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea. Am J Hypertens. 2003; 16:274-80. Search in Google Scholar

30 Khayat RN, Varadharaj S, Porter K, Sow A, Jarjoura D, Gavrilin MA, et al. Angiotensin Receptor Expression and Vascular Endothelial Dysfunction in Obstructive Sleep Apnea. Am J Hypertens. 2018; 31:355-61. Search in Google Scholar

31 Tsioufis C, Dimitriadis K, Katsiki N, Tousoulis D. Microcirculation in Hypertension: An Update on Clinical Significance and Therapy. Curr Vasc Pharmacol. 2015; 13:413-417. Search in Google Scholar

32 Laurent S, Boutouyrie P. The structural factor of hypertension: large and small artery alterations. Circ Res. 2015; 116:1007-1021. Search in Google Scholar

33 Annamalai AK, Webb A, Kandasamy N, Elkhawad M, Moir S, Khan F, Maki-Petaja K, Gayton EL, Strey CH, O'Toole S, Ariyaratnam S, Halsall DJ, Chaudhry AN, Berman L, Scoffings DJ, Antoun NM, Dutka DP, Wilkinson IB, Shneerson JM, Pickard JD, Simpson HL, Gurnell M. A comprehensive study of clinical, biochemical, radiological, vascular, cardiac, and sleep parameters in an unselected cohort of patients with acromegaly undergoing presurgical somatostatin receptor ligand therapy. J Clin Endocrinol Metab. 2013; 98:1040-1050. Search in Google Scholar

34 Sardella C, Urbani C, Lombardi M, Nuzzo A, Manetti L, Lupi I, Rossi G, Del Sarto S, Scattina I, Di Bello V, Martino E, Bogazzi F. The beneficial effect of acromegaly control on blood pressure values in normotensive patients. Clin Endocrinol (Oxf). 2014; 81:573-581. Search in Google Scholar

35 Minniti G, Moroni C, Jaffrain-Rea ML, Esposito V, Santoro A, Affricano C, Cantore G, Tamburrano G, Cassone R. Marked improvement in cardiovascular function after successful transsphenoidal surgery in acromegalic patients. Clin Endocrinol (Oxf). 2001; 55:307-313. Search in Google Scholar

36 Katznelson L, Laws ER, Jr, Melmed S, Molitch ME, Murad MH, Utz A, Wass JA, Endocrine Society Acromegaly: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism. 2014; 99:3933-3951. Search in Google Scholar